Acolyte devoted to bacterial detection

Published: 17-Oct-2005


Acolyte Biomedica and the Scottish National Blood Transfusion Service (SNBTS) have entered into a joint research programme to establish the suitability of Acolyte's proprietary Adenylate Kinase (AK) Rapid technology in the detection of bacterial contamination within blood platelets.

Under the agreement the parties will share resources to develop a version of Acolyte's BacLite diagnostic test system with the potential to detect bacteria in platelets within two to four hours, rather than over a period of several days, which current testing technologies require. AK technology was originally developed by the UK based Defence Science and Technology Laboratory, and Acolyte has been granted an exclusive licence to exploit it in the field of clinical diagnostics. If successful, the parties intend to extend the collaboration into a full product development. Acolyte was expected to launch its first commercial application of the AK technology in its BacLite Rapid MRSA screening test in mid-2005.

You may also like